(精编)Horizon Scanning for Drug教学课件.pptVIP

TYPE 2 DIABETES – CONSIDERATIONS FOR COMMISSIONERS AND PROVIDERS Ensure medicines related aspects are included in any service redesigns. Ensure local policies provide guidance on when stop newer treatments (e.g. SGLT2 inhibitors, gliptins and GLP-1 agonists) as well as when to initiate in line with NICE recommendations. Audit against NICE criteria for stopping. Ensure local guidance on self-monitoring of blood glucose by patients T2DM is in line with revised recommendations in NICE guideline. Consider developing a locally approved list of preferred meters and strips for monitoring blood